30
Pharmaceutical Compounds Pharmaceutical Compounds in our Water Supply: in our Water Supply: Causes, Consequences and Causes, Consequences and Solutions Solutions Hanoz Santoke Hanoz Santoke Weihua Song Weihua Song William Cooper William Cooper University of California, University of California, Irvine Irvine

Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

  • Upload
    halen

  • View
    26

  • Download
    0

Embed Size (px)

DESCRIPTION

Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions. Hanoz Santoke Weihua Song William Cooper University of California, Irvine. Outline. Introduction – pharmaceuticals in water, fluoroquinolones, advanced oxidation - PowerPoint PPT Presentation

Citation preview

Page 1: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Pharmaceutical Compounds in our Pharmaceutical Compounds in our Water Supply:Water Supply:

Causes, Consequences and Causes, Consequences and SolutionsSolutions

Hanoz SantokeHanoz SantokeWeihua SongWeihua Song

William CooperWilliam CooperUniversity of California, IrvineUniversity of California, Irvine

Page 2: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

OutlineOutline

• Introduction – pharmaceuticals in water, fluoroquinolones, advanced oxidation

• Methods and Materials – LINAC and mass spectroscopy

• Results and Discussion – transient spectra, rate constants, and degradation mechanisms

• Conclusions

Page 3: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Pharmaceuticals in Natural Bodies Pharmaceuticals in Natural Bodies of Waterof Water

• Dozens of pharmaceutical and personal care products detected in various rivers, streams and lakes

• Fluoroquinolone levels up to 0.12 g/L in various streams in the US (Kolpin 2002)

• Effluent from a Patancheru, India drug manufacturing facility contained many pharmaceuticals in the mg/L range, with six of the top eleven active pharmaceutical ingredients detected being fluoroquinolones (Larsson 2007)

Page 4: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Pharmaceuticals in our Drinking Pharmaceuticals in our Drinking WaterWater

• Pharmaceutical compounds, including antibiotics, anti-convulsants, mood stabilizers and sex hormones, have been detected at ppb levels in the drinking water supplies of at least 41 million Americans (Associated Press investigation, 2008)

No federal or state standards exist for pharmaceuticals in drinking water (tap or bottled)

Page 5: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Drinking Water Test ResultsDrinking Water Test Results

Source: Associated Press, 2008

Page 6: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Pathways to the EnvironmentPathways to the Environment

Human and animal excretion– High drug use in the

United States: 3.7 billion prescription and 3.3 billion non-prescription purchases per year

– Most drugs are incompletely metabolized in the body (Kummerer 2004)

Page 7: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Pathways to the Environment - Pathways to the Environment - continuedcontinued

• Dumped “down the drain” by consumers and medical facilities (Halling-Sorensen 1998)

• Manufacturing facilities (Larsson 2007)

Page 8: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Environmental ConsequencesEnvironmental Consequences

• Pharmaceutical compounds, including fluoroquinolones, are toxic to plants such as Lemna Gibba, which is commonly used as a test species for assessing aquatic toxicants (Brain 2004)

Page 9: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Environmental Consequences - Environmental Consequences - continuedcontinued

• Fluoroquinolones have been found to be toxic to various aquatic organisms, and their selective toxicity may impact ecosystem structure (Robinson 2005)

• A mixture of pharmaceuticals at environmental concentrations has been shown to inhibit the growth of human embryonic cells by as much as 30% (Pomati 2006)

Page 10: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Current Treatment TechnologiesCurrent Treatment Technologies

• Biodegradation• Nanofiltration• Activated carbon

adsorption• Ozonation• Reverse Osmosis

• Only reverse osmosis can effectively remove pharmaceuticals, but at very high cost

Page 11: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Advanced Oxidation/Reduction Advanced Oxidation/Reduction ProcessesProcesses

• Hydroxyl radicals – oxidizing agent

• Hydrated electrons – reducing agent

• Generated by radiating ozone or hydrogen peroxide

• Studies have shown that AOPs are very promising

(cheaper and more efficient) in removing

pharmaceutical compounds from water (Huber

2003)

Page 12: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

What are Fluoroquinolones?What are Fluoroquinolones?

• Quinolones are a set of broad-spectrum antibiotics

• Fluoroquinolones are quinolones with a fluorine atom

attached to the central ring

• 9 fluoroquinolones are currently FDA-approved for humans

• Levofloxacin (“Levaquin”) best-selling, $1.5 billion in 2006

• Adverse effects include nerve or tendon damage, and heart

problems

• Many types of bacteria have built up resistance

Page 13: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Target CompoundsTarget Compounds

N

F

N

NH3C

O

OH

O

danofloxacin MW 362

N

COH

OF

F

N

HN

H3C

CH3

F

O

orbif loxacin MW 395

N

F

N

NH3C

O O

OH

enrof loxacin MW 359

O N

N

F

N

N

O

OH

O

marbofloxacin MW 362

flumequine MW 261

F

N

O

OH

O

NH

F

O

OH

O

model compound MW 207

Page 14: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

ObjectivesObjectives

• Determine absolute bimolecular reaction rate constants

for the reactions of hydroxyl radicals and hydrated

electrons with several common fluoroquinolones

• Study degradation pathways to identify the byproducts

formed in the process.

• This information may be used to design an advanced

oxidation process to remove these compounds from

wastewater.

Page 15: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Degradation StudiesDegradation Studies

• Cesium-137 radiation source to prepare samples with various doses of radiation

• HPLC to measure concentrations of radiated samples

• Liquid chromatography - mass spectroscopy to identify molecular weights of byproducts and elucidate degradation mechanism

Page 16: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Degradation by Cesium RadiationDegradation by Cesium Radiation

Concentration of danofloxacin as a function of radiation dose

Page 17: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

LC-MS DataLC-MS Data

Defluorination of marbofloxacin: mass chromatograms for molecular weight 360, [M-H]‒=359, at various radiation doses.

Page 18: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Degradation PathwaysDegradation Pathways

N

F

A

C

O

OH

O

B

D

N

F

A

C

O

OH

O

B

OH

N

HO

A

O

OH

OD

N

F

HO

C

O

OH

O

B

D

N

HO

A

C

O

OH

O

B

OH

N

F

HO

C

O

OH

O

B

OH

N

HO

HO

C

O

OH

O

B

D

HA

+ F

+

(a)

(b)

(c)

CB

Page 19: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Degradation Pathways LegendDegradation Pathways Legend

Page 20: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Transient SpectraTransient Spectra

Page 21: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Transient Spectra ObservationsTransient Spectra Observations

• strong absorbance in the 350 to 400 nm range

• max of each intermediate was red-shifted by around 100 nm compared to that of the parent compound, characteristic of •OH addition to the aromatic ring to form the corresponding hydroxycyclohexadienyl radical

• Flumequine has the transient spectra most comparable to the model compound

Page 22: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Linear AcceleratorLinear Accelerator

Linear Accelerator at Notre Dame Radiation Laboratory to calculate absolute bimolecular reaction rate constants

Page 23: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

A few equationsA few equations

Radiolysis of water

H2O e-aq (0.27) + H• (0.06) + •OH (0.28)

+ H2 (0.05) + H2O2 (0.07) + H3O+(0.27)

Isolation of •OH • e-aq + N2O + H2O N2 + HO- + •OH• H• + N2O •OH + N2

Isolation of e-aq

• (CH3)2CHOH + •OH (CH3)2C•OH + H2O• (CH3)2CHOH + H• (CH3)2C•OH + H2

Page 24: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Calculation of Rate Constants: Calculation of Rate Constants: Hydroxyl RadicalHydroxyl Radical

Danofloxacin + hydroxyl radical

Pseudo-first order rate constant as a function of concentration.

0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50

1.0

1.5

2.0

2.5

3.0

3.5

Rat

e co

nst

ant

(106 s

-1)

Danofloxacin concentration (mM)

Page 25: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Calculation of Rate Constants: Calculation of Rate Constants: Hydrated ElectronHydrated Electron

Danofloxacin + hydrated electron

Pseudo-first order rate constant as a function of concentration.

0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

Rat

e co

nst

ant

(106 s

-1)

Danofloxacin concentration (mM)

Page 26: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Summary of ResultsSummary of Results

Compound·OH max

(nm)k (·OH) (M-1s-1) k (e-

aq) (M-1s-1)

-irradiation Half life (kGy)

Orbifloxacin 370 (6.94 ± .08) x 109 (2.25 ± .02) x 1010 1.56

Flumequine 360 (8.26 ± .28) x 109 (1.83 ± .01) x 1010 1.64

Marbofloxacin 400 (9.03 ± .39) x 109 (2.41 ± .02) x 1010 1.80

Danofloxacin 440 (6.15 ± .11) x 109 (1.68 ± .02) x 1010 1.85

Enrofloxacin 400 (7.95 ± .23) x 109 (1.89 ± .02) x 1010 1.38

Model compound

350 (7.65 ± .20) x 109 (1.49 ± .01) x 1010 0.05

Page 27: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Degradation Pathways LegendDegradation Pathways Legend

Page 28: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

Rate Constant TrendsRate Constant Trends

• Piperazine ring provides steric hindrance, which decreases ·OH rate constant

• Electron-donating oxygen atom increases ·OH rate constant

• Cyclopropane functional group appears to reduce rate constants

Page 29: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

ConclusionsConclusions

• Pharmaceutical residue in our drinking water is a major environmental and human health issue

• Advanced Oxidation/Reduction Processes hold great promise for the removal of pharmaceutical compounds

• This work helps us understand the reactions of fluoroquinolones with hydroxyl radicals, which will be useful in designing a pilot-scale AO/RP system

Page 30: Pharmaceutical Compounds in our Water Supply: Causes, Consequences and Solutions

If you gave me several million years, there would be nothing that did If you gave me several million years, there would be nothing that did not grow in beauty if it were surrounded by water.not grow in beauty if it were surrounded by water.

- - Jan Erik Vold, What All The World Knows, 1970Jan Erik Vold, What All The World Knows, 1970

Thank you!Thank you! Questions?